There shall be no administrative or judicial review of any of the following:

(1) The determination of a unit, with respect to a drug or biological product, pursuant to section 1320f(c)(6) of this title.

(2) The selection of drugs under section 1320f-1(b) of this title, the determination of negotiation-eligible drugs under section 1320f-1(d) of this title, and ¹ the determination of qualifying single source drugs under section 1320f-1(e) of this title the ² application of section 1320f-1(f) of this title,.³

(3) The determination of a maximum fair price under subsection (b) or (f) of section 1320f-3 of this title.

(4) The determination of renegotiation-eligible drugs under section 1320f-3(f)(2) of this title and the selection of renegotiation-eligible drugs under section 1320f-3(f)(3) of this title.